An Algorithm for Generating Individualized Treatment Decision Trees and Random Forests
暂无分享,去创建一个
Hua Zhou | Haoda Fu | Jin Zhou | Kevin Doubleday | Hua Zhou | H. Fu | Kevin Doubleday | Jin J. Zhou
[1] B. Wolffenbuttel,et al. DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results , 2009, Diabetes Care.
[2] Xin Yan,et al. Facilitating score and causal inference trees for large observational studies , 2012, J. Mach. Learn. Res..
[3] F. Cognetti,et al. HER2 and response to paclitaxel in node-positive breast cancer. , 2008, The New England journal of medicine.
[4] Eric B. Laber,et al. Tree-based methods for individualized treatment regimes. , 2015, Biometrika.
[5] Eric B. Laber,et al. A Robust Method for Estimating Optimal Treatment Regimes , 2012, Biometrics.
[6] I. van Mechelen,et al. Qualitative interaction trees: a tool to identify qualitative treatment–subgroup interactions , 2014, Statistics in medicine.
[7] Marie Davidian,et al. Using decision lists to construct interpretable and parsimonious treatment regimes , 2015, Biometrics.
[8] Trevor Hastie,et al. The Elements of Statistical Learning , 2001 .
[9] J. Morgan,et al. Problems in the Analysis of Survey Data, and a Proposal , 1963 .
[10] J. M. Taylor,et al. Subgroup identification from randomized clinical trial data , 2011, Statistics in medicine.
[11] J. Weinstein,et al. Biomarkers in Cancer Staging, Prognosis and Treatment Selection , 2005, Nature Reviews Cancer.
[12] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .
[13] Andy Liaw,et al. Classification and Regression by randomForest , 2007 .
[14] G. Meininger,et al. Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone , 2014, Diabetes, obesity & metabolism.
[15] R. Bergenstal,et al. Type 2 diabetes: assessing the relative risks and benefits of glucose-lowering medications. , 2010, The American journal of medicine.
[16] Peter Doyle,et al. The Use of Automatic Interaction Detector and Similar Search Procedures , 1973 .
[17] L. Tian,et al. Analysis of randomized comparative clinical trial data for personalized treatment selections. , 2011, Biostatistics.
[18] G. Tutz,et al. An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests. , 2009, Psychological methods.
[19] Min Zhang,et al. Estimating optimal treatment regimes from a classification perspective , 2012, Stat.
[20] S. Murphy,et al. PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES. , 2011, Annals of statistics.
[21] Lu Tian,et al. Effectively Selecting a Target Population for a Future Comparative Study , 2013, Journal of the American Statistical Association.
[22] L. Wood,et al. The General Practice Research Database , 2004, Drug safety.
[23] G. Ginsburg,et al. The path to personalized medicine. , 2002, Current opinion in chemical biology.
[24] D H Lawson,et al. The General Practice Research Database. Scientific and Ethical Advisory Group. , 1998, QJM : monthly journal of the Association of Physicians.
[25] Hansheng Wang,et al. Subgroup Analysis via Recursive Partitioning , 2009, J. Mach. Learn. Res..
[26] F. Collins,et al. The path to personalized medicine. , 2010, The New England journal of medicine.
[27] Leo Breiman,et al. Bagging Predictors , 1996, Machine Learning.
[28] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[29] Wei-Yin Loh,et al. Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..
[30] Haoda Fu,et al. Estimating optimal treatment regimes via subgroup identification in randomized control trials and observational studies , 2016, Statistics in medicine.
[31] Menggang Yu,et al. Regularized outcome weighted subgroup identification for differential treatment effects , 2015, Biometrics.
[32] Honghua H. Jiang,et al. Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a prospective randomized open-label trial , 2013, Diabetes, obesity & metabolism.
[33] Corinna Cortes,et al. Support-Vector Networks , 1995, Machine Learning.
[34] Luc Van Gaal,et al. Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial. , 2014, The lancet. Diabetes & endocrinology.
[35] K. Imai,et al. Estimation of Heterogeneous Treatment Effects from Randomized Experiments, with Application to the Optimal Planning of the Get-Out-the-Vote Campaign , 2011, Political Analysis.
[36] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[37] Roland A Matsouaka,et al. Evaluating marker‐guided treatment selection strategies , 2014, Biometrics.
[38] A. Kitabchi,et al. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. , 2011, Metabolism: clinical and experimental.
[39] I. Lipkovich,et al. Subgroup identification based on differential effect search—A recursive partitioning method for establishing response to treatment in patient subpopulations , 2011, Statistics in medicine.
[40] Ilya Lipkovich,et al. Local control for identifying subgroups of interest in observational research: persistence of treatment for major depressive disorder , 2013, International journal of methods in psychiatric research.
[41] Donglin Zeng,et al. Estimating Individualized Treatment Rules Using Outcome Weighted Learning , 2012, Journal of the American Statistical Association.
[42] W. Loh,et al. REGRESSION TREES WITH UNBIASED VARIABLE SELECTION AND INTERACTION DETECTION , 2002 .
[43] D. M. Grant,et al. The Art and Science of Personalized Medicine , 2007, Clinical pharmacology and therapeutics.
[44] Dag Aarsland,et al. Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations. , 2010, Journal of Alzheimer's disease : JAD.
[45] Bruce H. R. Wolffenbuttel,et al. The DURABLE Trial 24-week Results: Safety and Efficacy of Insulin Lispro Mix 75/25 Versus Insulin Glargine Added to Oral Antihyperglycemic Drugs in Patients with Type 2 Diabetes , 2009 .